Vinge advised Apotea on the deal. Apotea AB (publ) completed its listing on Nasdaq Stockholm. The offering price was SEK 58 per ordinary share, corresponding to a...
Vinge advised Apotea on the deal. Apotea AB (publ) completed its listing on Nasdaq Stockholm. The offering price was SEK 58 per ordinary share, corresponding to a...
You must be a Standard 1 Year member to access this content.